This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Millan, V. G. Articles by Madias, N. E. Search for Related Content PubMed PubMed Citation Articles by Millan, V. G. Articles by Madias, N. E.

Hypertension, Vol 7, 668-674, Copyright © 1985 by American Heart Association

ARTICLES

Percutaneous transluminal renal angioplasty in nonatherosclerotic renovascular hypertension. Long-term results

VG Millan, J McCauley, RI Kopelman and NE Madias

Nineteen stenotic arteries in 16 patients with severe renovascular hypertension of nonatherosclerotic nature (fibromuscular dysplasia in 13, neurofibromatosis in 3) were treated with percutaneous transluminal renal angioplasty. The procedure was technically successful in 12 of 14 (86%) stenoses in the fibromuscular dysplasia subgroup but in only one of five (20%) lesions in the neurofibromatosis subgroup. Hypertension was abated (3 patients) or disappeared (8 patients) in 11 of the 12 (92%) patients with fibromuscular dysplasia who had a technically successful angioplasty, an effect that was sustained at latest follow- up (avg, 37 mo; range, 10-73 mo). The only complication encountered was a retroperitoneal hematoma that resolved uneventfully. Coupled with those from other centers, the results of the present study indicate that angioplasty offers a strong potential for curability in patients with renovascular hypertension caused by fibromuscular dysplasia and that percutaneous transluminal renal angioplasty should be considered the treatment of choice for the initial management of all patients with fibromuscular renovascular hypertension.

This article has been cited by other articles:

				K. T. Delis Commentary on "Inferior Mesenteric Artery Aneurysm Combined With Renal Artery Stenosis in a Patient With Neurofibromatosis" Perspectives in Vascular Surgery and Endovascular Therapy, September 1, 2006; 18(3): 221 - 223. [PDF]

				K. T. Delis and P. Gloviczki Neurofibromatosis Type 1: From Presentation and Diagnosis to Vascular and Endovascular Therapy Perspectives in Vascular Surgery and Endovascular Therapy, September 1, 2006; 18(3): 226 - 237. [Abstract] [PDF]

				C. Booth, R. Preston, G. Clark, and J. Reidy Management of renal vascular disease in neurofibromatosis type 1 and the role of percutaneous transluminal angioplasty Nephrol. Dial. Transplant., July 1, 2002; 17(7): 1235 - 1240. [Abstract] [Full Text] [PDF]

				U. Blum, B. Krumme, P. Flugel, A. Gabelmann, T. Lehnert, C. Buitrago-Tellez, P. Schollmeyer, and M. Langer Treatment of Ostial Renal-Artery Stenoses with Vascular Endoprostheses after Unsuccessful Balloon Angioplasty N. Engl. J. Med., February 13, 1997; 336(7): 459 - 465. [Abstract] [Full Text] [PDF]